| Schedule of Segment Reporting |
Selected financial information for the
Company’s operating segments is as follows:
| |
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
| |
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
| Net revenues - External |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
586,663 |
|
|
$ |
(9,085 |
) |
|
$ |
1,994,639 |
|
|
$ |
3,461,987 |
|
| Supportive Software Solutions |
|
|
208,070 |
|
|
|
50,447 |
|
|
|
698,359 |
|
|
|
605,575 |
|
| Hospital Operations |
|
|
619,478 |
|
|
|
- |
|
|
|
619,478 |
|
|
|
- |
|
| |
|
$ |
1,414,211 |
|
|
$ |
41,362 |
|
|
$ |
3,312,476 |
|
|
$ |
4,067,562 |
|
| Net revenues - Intersegment (***) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Supportive Software Solutions |
|
|
217,431 |
|
|
|
502,055 |
|
|
|
501,924 |
|
|
|
1,036,396 |
|
| |
|
$ |
217,431 |
|
|
$ |
502,055 |
|
|
$ |
501,924 |
|
|
$ |
1,036,396 |
|
| (Loss) income from operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
(1,039,118 |
) |
|
$ |
(7,364,096 |
) |
|
$ |
(3,809,146 |
) |
|
$ |
(10,590,435 |
) |
| Supportive Software Solutions |
|
|
(660,800 |
) |
|
|
(1,253,386 |
) |
|
|
(1,721,694 |
) |
|
|
(3,800,893 |
) |
| Hospital Operations |
|
|
(2,093,805 |
) |
|
|
- |
|
|
|
(3,114,473 |
) |
|
|
- |
|
| Corporate |
|
|
(1,369,765 |
) |
|
|
(2,940,956 |
) |
|
|
(5,058,565 |
) |
|
|
(7,059,644 |
) |
| Eliminations |
|
|
- |
|
|
|
33,663 |
|
|
|
8,181 |
|
|
|
100,987 |
|
| |
|
$ |
(5,163,488 |
) |
|
$ |
(11,524,775 |
) |
|
$ |
(13,695,697 |
) |
|
$ |
(21,349,985 |
) |
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
410,801 |
|
|
$ |
549,748 |
|
|
$ |
1,265,174 |
|
|
$ |
1,646,167 |
|
| Supportive Software Solutions |
|
|
25,015 |
|
|
|
163,749 |
|
|
|
227,999 |
|
|
|
490,236 |
|
| Hospital Operations |
|
|
15,436 |
|
|
|
- |
|
|
|
22,045 |
|
|
|
- |
|
| Corporate |
|
|
345 |
|
|
|
745 |
|
|
|
1,005 |
|
|
|
2,494 |
|
| Eliminations |
|
|
- |
|
|
|
(33,663 |
) |
|
|
(8,181 |
) |
|
|
(100,987 |
) |
| |
|
$ |
451,597 |
|
|
$ |
680,579 |
|
|
$ |
1,508,042 |
|
|
$ |
2,037,910 |
|
| Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
6,000 |
|
| Supportive Software Solutions |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
9,998 |
|
| Hospital Operations |
|
|
160,413 |
|
|
|
- |
|
|
|
1,554,499 |
|
|
|
- |
|
| |
|
$ |
160,413 |
|
|
$ |
- |
|
|
$ |
1,554,499 |
|
|
$ |
15,998 |
|
***` Intersegment revenues are eliminated in consolidation.
| |
|
September 30, 2017 |
|
|
December 31, 2016 |
|
| Total assets |
|
|
|
|
|
|
|
|
| Clinical Laboratory Operations |
|
$ |
1,686,167 |
|
|
$ |
3,986,126 |
|
| Supportive Software Solutions |
|
|
1,767,251 |
|
|
|
2,602,428 |
|
| Decision Support and Informatics |
|
|
- |
|
|
|
60,000 |
|
| Hospital Operations |
|
|
1,748,986 |
|
|
|
- |
|
| Corporate |
|
|
3,037,112 |
|
|
|
2,130,191 |
|
| Assets of AMSG classified as held for sale |
|
|
997,497 |
|
|
|
414,662 |
|
| Eliminations |
|
|
(2,871,080 |
) |
|
|
(2,711,014 |
) |
| |
|
$ |
6,365,933 |
|
|
$ |
6,482,393 |
|
|